Skip to main content

Apple’s Services Surprise Pleases Wall Street

Apple managed to surprise investors in a good way on Tuesday by reporting better-than-expected quarterly results and by giving an upbeat forecast for the current quarter.

But the encouraging performance had nothing to do with the iPhone, Apple’s growth engine over the past decade that propelled the company from also-ran computer maker to one of the world’s most profitable corporations. Instead, it was strong growth in services like Apple Music, Apple Pay, and app sales that excited investors.

CEO Tim Cook is increasingly turning to services as smartphone sales slow worldwide. Customers are now holding onto their phones for three to four years on average before upgrading, so Apple’s growth these days depends partly on selling more services. Later this year, the company plans to introduce a couple of important ones, for video gaming and video streaming.

Additionally, Apple is trying to push beyond its reliance on iPhone, iPad and computer sales. Apple Watch and AirPod earbuds are central to that strategy.

For the just-completed quarter, Apple said it had $53.8 billion in revenue, up 1% from a year earlier and about $400 million more than Wall Street analysts had expected. Profit per share of $2.18 was down 7% from last year, but 8 cents better than analysts had expected.

The biggest surprise was in Apple’s forecast for revenue in the current quarter of between $61 billion and $64 billion. Wall Street had expected only $61 billion.

Apple’s stock price, already up 33% in 2019, jumped another 4% in aftermarket trading on Tuesday, putting the company’s stock market value again near $1 trillion.

Breaking down the results, sales of iPhones plunged 12% to $26 billion, the third straight quarter of decline (Apple no longer discloses how may devices it sold–just the sales total). But services sales, now the company’s second-largest business, jumped 13% to $11.5 billion.

Although rivals like Google and Facebook usually get more credit for attracting consumers to their services, Apple said it now has more than 420 million customers paying for at least one service, which could be anything from $10 monthly for Apple Music to $199 for two years of extended warranty coverage on an iPhone XS. “Our subscription business continues to grow strongly and is extremely diversified across many categories,” chief financial officer Luca Maestri told analysts on a call on Tuesday afternoon.

Asked about the company’s surprisingly strong forecast for growth in the current quarter, Maestri again pointed to services along with the “wearables” division that includes Apple Watch and AirPods. “These two categories have become really important and really large for us,” he said.



from Fortune https://ift.tt/2K5FT1E

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be